Latest Brainchip (ASX:BRN) News

BrainChip Holdings has closed its Share Purchase Plan with subscriptions exceeding the $2 million target by nearly $1 million, complementing a recent $35 million placement. The Board’s decision to accept all applications reflects robust shareholder confidence.

BrainChip Holdings Ltd has launched a fully underwritten $35 million placement alongside a $2 million share purchase plan to fund the commercialization of its Akida 2.0 technology and new TENNs product development. The capital raise underscores the company’s commitment to expanding its footprint in the rapidly growing edge AI market.

BrainChip Holdings Ltd has secured A$35 million through a fully underwritten placement and an additional A$2 million via a Share Purchase Plan to fast-track its neuromorphic AI technology and product development.

BrainChip Holdings has moved its AKD1500 neuromorphic AI chip into volume production, supported by key supply agreements and expanded distribution channels, while maintaining a stable cash position.

BrainChip Holdings Ltd showcased its leadership in ultra-low-power edge AI technology, emphasizing strong partnerships and a growing product portfolio targeting high-growth sectors like defense and healthcare.

BrainChip Holdings has initiated tape-out for its AKD1500 neuromorphic AI chip, targeting volume production by late Q3 2026 to meet rising demand for ultra-low-power edge AI solutions.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.

BrainChip Holdings Ltd’s 2025 AGM reveals a strengthened product roadmap, breakthrough Edge AI technology advances, and a surge in commercial partnerships, positioning the company for accelerated growth.

BrainChip Holdings advanced its neuromorphic AI technology through significant contracts with the Swedish National Space Agency and the U.S. Air Force, while exploring a potential redomiciling to the US. The company reported steady cash outflows and ongoing strategic partnerships.

BrainChip Holdings reports a US$20 million cash balance and key defense contracts in its December 2024 quarterly update, underscoring its growing foothold in neuromorphic AI commercialization.